tiprankstipranks
Trending News
More News >
Astria Therapeutics (ATXS)
NASDAQ:ATXS
US Market
Advertisement

Astria Therapeutics (ATXS) Technical Analysis

Compare
1,160 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Astria Therapeutics’s (ATXS) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting Astria Therapeutics is a Sell.
Astria Therapeutics’s (ATXS) 20-Day exponential moving average is 7.47, while Astria Therapeutics’s (ATXS) share price is $8.4, making it a Buy.
Astria Therapeutics’s (ATXS) 50-Day exponential moving average is 7.07, while Astria Therapeutics’s (ATXS) share price is $8.4, making it a Buy.

Astria Therapeutics (ATXS) Pivot Points

Oct 10, 2025, 05:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.87
7.11
7.29
7.54
7.71
7.96
8.14
Fibonacci
7.11
7.27
7.37
7.54
7.70
7.80
7.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Astria Therapeutics (ATXS) Moving Averages

Oct 10, 2025, 05:36 AM
Period
Simple
Exponential
MA5
7.75Buy
7.82Buy
MA10
7.54Buy
7.64Buy
MA20
7.47Buy
7.47Buy
MA50
7.05Buy
7.07Buy
MA100
6.34Buy
6.76Buy
MA200
6.37Buy
7.20Buy
Astria Therapeutics’s (ATXS) 10-Day exponential moving average is 7.64, while Astria Therapeutics’s (ATXS) share price is $8.4, making it a Buy.
Astria Therapeutics’s (ATXS) 100-Day exponential moving average is 6.76, while Astria Therapeutics’s (ATXS) share price is $8.4, making it a Buy.
Astria Therapeutics’s (ATXS) stock price is $8.4 and Astria Therapeutics’s (ATXS) 50-day simple moving average is 7.05, creating a Buy signal.
Astria Therapeutics’s (ATXS) stock price is $8.4 and Astria Therapeutics’s (ATXS) 100-day simple moving average is 6.34, creating a Buy signal.
Astria Therapeutics’s (ATXS) stock price is $8.4 and Astria Therapeutics’s (ATXS) 200-day simple moving average is 6.37, creating a Buy signal.

Astria Therapeutics (ATXS) Technical Indicators

Oct 10, 2025, 05:36 AM
Name
Value
Implied Action
RSI (14)
66.50
Neutral
STOCH (9,6)
77.78
Neutral
STOCHRSI (14)
79.71
Neutral
MACD (12,26)
0.22
Sell
ADX (14)
10.34
Buy
Williams %R
0.00
Buy
CCI (14)
262.62
Sell
ATR (14)
0.46
-
Ultimate Oscillator
60.12
Neutral
ROC
12.30
Buy
Astria Therapeutics’s (ATXS) Relative Strength Index (RSI) is 66.50, creating a Neutral signal.
Astria Therapeutics’s (ATXS) Trend Strength Indicator (ADX) is 10.34, creating a Buy signal.
Astria Therapeutics’s (ATXS) Commodity Channel Index (CCI) is 262.62, creating a Sell signal.
Astria Therapeutics’s (ATXS) Price Rate of Change (ROC) is 12.30, creating a Buy signal.

FAQ

Is ATXS a Buy, Hold, or Sell?
Based on ATXS’s technical indicators, ATXS is a Strong Buy.
    What is ATXS’s RSI (14)?
    ATXS’s RSI (14) is 66.50, which suggests ATXS is a Neutral.
      What is ATXS’s MACD?
      ATXS’s MACD is 0.22, which suggests ATXS is a Sell.
        What is ATXS’s 5-day moving average?
        ATXS’s 5-day moving average is 7.75, which suggests ATXS is a Buy.
          What is ATXS’s 20-day moving average?
          ATXS 20-day moving average is 7.47, which suggests ATXS is a Buy.
            What is ATXS’s 50-day moving average?
            ATXS’s 50-day moving average is 7.05, which suggests ATXS is a Buy.
              What is ATXS’s 200-day moving average?
              ATXS’s 200-day moving average is 6.37, which suggests ATXS is a Buy.
                What is ATXS’s Williams % R (14)?
                ATXS’s Williams % R (14) is 0.00, which suggests ATXS is a Buy.
                  What is ATXS’s CCI (14)?
                  ATXS’s CCI (14) is 262.62, which suggests ATXS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis